Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis

被引:58
作者
Dai, Jian-Ping [1 ]
Chen, Jun [1 ]
Bei, Yu-Fei [1 ]
Han, Bang-Xing [1 ]
Wang, Sheng [1 ]
机构
[1] Jiangsu Univ, Sch Food & Bioengn, Zhenjiang 212013, Jiangsu, Peoples R China
关键词
matrix metalloproteinases; oral mucosa; submucous fibrosis; IN-VITRO; PROLIFERATION; MANAGEMENT; LYCOPENE; EFFICACY; TAIWAN;
D O I
10.1111/j.1600-0714.2008.00738.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Borneol, a widely used food and cosmetics additive, has analgesic, anti-inflammatory, antibacterial and penetration enhancing effects. We try to use it as a penetration enhancer for a formula which we have used to treat oral submucous fibrosis (OSF). To assess its safety, we investigate its effects on primary mice oral fibroblasts. Primary mice oral fibroblasts were cultured, the effects of borneol on fibroblasts proliferation, cytotoxicity, collagen production, matrix metalloproteinases-2,9 (MMP-2,9) activities and tissue inhibitors of metalloproteinase 1 (TIMP-1) production were tested by methyl thiazolyl tetrazolium assay, lactic dehydrogenase activity assay, chloramine T method, gelatin zymography and enzyme-linked immunosorbent assay, respectively. Borneol, from 18.75 to 300 mu g/ml, could significantly (P < 0.05) decrease the growth of fibroblasts and very significantly (P < 0.01) inhibit collagen production in a concentration dependant manner. From 18.75 to 150 mu g/ml, borneol had no cytotoxicity on mice oral fibroblasts. Moreover borneol could significantly (P < 0.05) decrease MMP-2 activity, and very significantly (P < 0.01) inhibit TIMP-1 production. This study indicates that borneol has anti-fibrosis activity and the mechanism may partly be relevant to its inhibiting effects on fibroblasts mitosis, collagen and TIMP-1 production. It can be safely used as a penetration enhancer for our formula to treat OSF.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 17 条
  • [1] MODIFIED ASSAY FOR DETERMINATION OF HYDROXYPROLINE IN A TISSUE HYDROLYZATE
    EDWARDS, CA
    OBRIEN, WD
    [J]. CLINICA CHIMICA ACTA, 1980, 104 (02) : 161 - 167
  • [2] Characterization of matrix metalloproteinases produced by rat alveolar macrophages
    Gibbs, DF
    Warner, RL
    Weiss, SJ
    Johnson, KJ
    Varani, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (06) : 1136 - 1144
  • [3] INCIDENCE RATES OF ORAL-CANCER AND NATURAL-HISTORY OF ORAL PRE-CANCEROUS LESIONS IN A 10-YEAR FOLLOW-UP-STUDY OF INDIAN VILLAGERS
    GUPTA, PC
    MEHTA, FS
    DAFTARY, DK
    PINDBORG, JJ
    BHONSLE, RB
    JALNAWALLA, PN
    SINOR, PN
    PITKAR, VK
    MURTI, PR
    IRANI, RR
    SHAH, HT
    KADAM, PM
    IYER, KSS
    IYER, HM
    HEGDE, AK
    CHANDRASHEKAR, GK
    SHROFF, BC
    SAHIAR, BE
    MEHTA, MN
    [J]. COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1980, 8 (06) : 287 - 333
  • [4] The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis
    Hu Yanjia
    Jian Xinchun
    [J]. CLINICA CHIMICA ACTA, 2007, 383 (1-2) : 51 - 56
  • [5] Efficacy of oral lycopene in the management of oral submucous fibrosis - Commentary
    Kerr, A. Ross
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 103 (02): : 214 - 215
  • [6] Kotan R, 2007, Z NATURFORSCH C, V62, P507
  • [7] Efficacy of lycopene in the management of oral submucous fibrosis
    Kumar, Abhinav
    Bagewadi, Anjana
    Keluskar, Vaishah
    Singh, Mohitpal
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 103 (02): : 207 - 213
  • [8] Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function
    Lin, H-J
    Lin, J-C
    [J]. ORAL DISEASES, 2007, 13 (04) : 407 - 413
  • [9] Liu Yu-De, 2008, Zhongguo Zhong Yao Za Zhi, V33, P259
  • [10] MALIGNANT TRANSFORMATION RATE IN ORAL SUBMUCOUS FIBROSIS OVER A 17-YEAR PERIOD
    MURTI, PR
    BHONSLE, RB
    PINDBORG, JJ
    DAFTARY, DK
    GUPTA, PC
    MEHTA, FS
    [J]. COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1985, 13 (06) : 340 - 341